Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| BIIB | Biogen, Inc. | 0.29% | 300.26 | 1.4% | $596.56m | |
| AMGN | Amgen, Inc. | 0.15% | 233.77 | 1.3% | $511.86m | |
| GILD | Gilead Sciences, Inc. | 1.74% | 67.08 | 1.0% | $364.16m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.06% | 372.26 | 2.6% | $296.10m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.08% | 223.25 | 1.9% | $267.50m | |
| ILMN | Illumina, Inc. | 2.08% | 326.47 | 3.5% | $239.80m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 6.02% | 113.89 | 2.0% | $195.68m | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | 2.66% | 67.27 | 12.0% | $195.66m | |
| EXAS | EXACT Sciences Corp. | 3.15% | 86.24 | 24.0% | $182.79m | |
| CLVS | Clovis Oncology, Inc. | 8.47% | 9.61 | 14.7% | $181.81m | |
| SRPT | Sarepta Therapeutics, Inc. | -0.46% | 109.46 | 14.6% | $145.45m | |
| A | Agilent Technologies, Inc. | 0.88% | 82.25 | 1.6% | $143.48m | |
| NBIX | Neurocrine Biosciences, Inc. | 0.28% | 116.81 | 5.0% | $128.05m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -0.20% | 79.92 | 4.3% | $126.79m | |
| SGEN | Seattle Genetics, Inc. | 0.29% | 117.50 | 6.1% | $126.10m |
Company Profile
Eiger BioPharmaceuticals, Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of well-characterized drugs for life-threatening, rare and ultra-rare diseases with high unmet medical needs and no approved therapies. The company was founded by David A. Cory on November 6, 2008 and is headquartered in Palo Alto, CA.